PARE ANTHONY (Chief Commercial Officer) sold 23.3% of their position (9.62K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $17.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/18/2021ACC: 0000899243-21-012547
Officer· Chief Commercial Officer
Since Jan 2020
-9.62K
Net shares
Net seller
$17.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.62K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.62K
Price / share
$1.84
Trade value
$17.70K
% of position
23.3%
3/17/2021
41.23K→31.61K
Total
Net shares
−9.62K
Net value
-$17.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2021 | S · Sale | −9.62K | $1.84 | $17.70K | 23.3% | 41.23K | 31.61K |
| Total | −9.62K | -$17.70K | ||||||
Derivative Transactions0
No derivative transactions reported